Assuming drug is required, the following results were found.

  • Aubagio (teriflunomide)

    Table of contents FDA warnings This drug has boxed warnings. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). It alerts doctors and patients about drug effects that may be dangerous. Severe liver damage. Aubagio...

    https://mschristian.org/index.php/blog/aubagio-teriflunomide
  • Tecfidera (dimethyl fumarate)

    It's available in two strengths: 120-mg capsules and 240-mg capsules. Tecfidera generic name Tecfidera is a brand-name drug. It's not currently available as a generic drug. Tecfidera contains the drug dimethyl fumarate. Table of contents What is...

    https://mschristian.org/index.php/blog/tecfidera-dimethyl-fumarate
  • Pharmacy Benefit Managers and Their Role in Drug Spending - Are they the Good Guys or Bad Guys

    April 2019 Pharmacy benefit manager have a significant behind-the-scenes impact in determining drug costs and patients’ access to medications. Some experts think pharmacy benefit managers need to move their business model away from securing rebates...

    https://mschristian.org/index.php/blog/pharmacy-benefit-managers-and-their-role-in-drug-spending-are-they-the-good-guys-or-bad-guys
  • My Top 3 Drug Stocks to Buy in the Market Crash - The Motley Fool

    Drug stocks are tumbling as investors worry about how the coronavirus outbreak may impact their operations. The pandemic, which is halting a great part of the world economy, may also slow clinical trials, drug development, and drug manufacturing. In...

    https://mschristian.org/index.php/blog/my-top-3-drug-stocks-to-buy-in-the-market-crash-the-motley-fool
  • Electronic Drug Delivery Systems Market Size Reach US$ 12.1 Billion by 2026 - Yahoo Finance

    The electronic drug delivery systems market size is expected to reach around US$ 12.1 Bn by 2026 growing at a CAGR of 8.9% from forecast period 2019 to 2026. LOS ANGELES, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Acumen Research and Consulting, a global...

    https://mschristian.org/index.php/blog/electronic-drug-delivery-systems-market-size-reach-us-12-1-billion-by-2026-yahoo-finance
  • Top 9 Drugs With the Biggest Price Increases Over 2 Years - Pharmacy Times

    Nine widely-used medications have experienced substantial price surges over the past 2 years, adding $5.1 billion to overall drug spending during this time period, according to a new report. Furthermore, 7 of these 9 drugs were found by the Institute of...

    https://mschristian.org/index.php/blog/top-9-drugs-with-the-biggest-price-increases-over-2-years-pharmacy-times
  • How cannabis and cannabis-based drugs harm the brain

    de Medicina MolecularSummary:A new study shows that the long-term use of either cannabis or cannabis-based drugs impairs memory. FULL STORY A new study led by Ana Sebastião, group leader at Instituto de Medicina Molecular João Lobo Antunes and Professor...

    https://mschristian.org/index.php/blog/how-cannabis-and-cannabis-based-drugs-harm-the-brain
  • GW Pharmaceuticals’ Cannabis-Based Epilepsy Drug Sales Grow - Barron's

    of its appearance at this week’s J.P. Morgan Healthcare Conference, GW Pharmaceuticals, the only company with an approved drug derived from cannabis, says that 2019 sales came in better than expected. The British drug company said on Sunday that its...

    https://mschristian.org/index.php/blog/gw-pharmaceuticals-cannabis-based-epilepsy-drug-sales-grow-barron-s
  • Humira, Rituxan top list of U.S. drugs with biggest price increases: report - Physician's Weekly

    By Caroline Humer NEW YORK (Reuters) – AbbVie Inc’s arthritis drug Humira and Roche Holding AG’s cancer drug Rituxan topped a list of seven treatments whose combined 2017 and 2018 price hikes accounted for a $5.1 billion increase in U.S. spending, a...

    https://mschristian.org/index.php/blog/humira-rituxan-top-list-of-u-s-drugs-with-biggest-price-increases-report-physician-s-weekly
  • Novartis CEO: Malaria drug is biggest hope against coronavirus - SonntagsZeitung - Reuters

    March 29 (Reuters) - Novartis Chief Executive Vas Narasimhan said his Sandoz generics unit’s malaria, lupus and arthritis drug hydroxychloroquine is the company’s biggest hope against the coronavirus, Swiss newspaper SonntagsZeitung reported on Sunday....

    https://mschristian.org/index.php/blog/novartis-ceo-malaria-drug-is-biggest-hope-against-coronavirus-sonntagszeitung-reuters
  • European 'Brain-Boosting' Drug Pushed as Supplement in U.S.

    A supposed "brain-boosting" drug that the FDA previously rejected as a supplement can easily be bought online, and can deliver doses far above normal, researchers found. Although piracetam is approved in Europe to treat cognitive impairment, it was...

    https://mschristian.org/index.php/blog/european-brain-boosting-drug-pushed-as-supplement-in-u-s
  • Infusion Treatments: Benefits and Side Effects

    and how they help treat MS. Q&A: Administering infusion treatments Q: How are infusion treatments given? A: These drugs are injected intravenously. This means you receive them through your vein. However, you don’t inject these medications yourself. You...

    https://mschristian.org/index.php/blog/infusion-treatments-benefits-and-side-effects
  • Stroke drug may also prevent Alzheimer's disease

    Date:Source:Rockefeller University PressSummary:Researchers have discovered that a drug currently being developed to treat stroke patients could also prevent Alzheimer's disease. The study shows that the genetically engineered protein 3K3A-APC protects...

    https://mschristian.org/index.php/blog/stroke-drug-may-also-prevent-alzheimer-s-disease
  • Watchdog group cites 7 best-selling drugs it says didn’t warrant price increases - The Boston Globe

    Tecfidera’s net price, after rebates and discounts by its Cambridge drug maker, went up 9.8 percent in those two years, from $99 to $109 for a single 240-milligram pill, raising health care costs by $313 million, according to a report Tuesday by the...

    https://mschristian.org/index.php/blog/watchdog-group-cites-7-best-selling-drugs-it-says-didn-t-warrant-price-increases-the-boston-globe
  • Can naltrexone help with multiple sclerosis (MS)?

    Table of contents Naltrexone, in low doses, has recently become a popular drug for treating multiple sclerosis. This is an off-label use, and research into its effectiveness is still underway. Multiple sclerosis (MS) is a disease that damages the nerve...

    https://mschristian.org/index.php/blog/can-naltrexone-help-with-multiple-sclerosis-ms-1
  • How cannabis and cannabis-based drugs harm your brain

    Long-term use of either cannabis or cannabis-based drugs impairs memory say researchers. The study has implications for both recreational users and people who use the drug to combat epilepsy, multiple sclerosis and chronic pain. They found that mice...

    https://mschristian.org/index.php/blog/how-cannabis-and-cannabis-based-drugs-harm-your-brain
  • Suing Device Firms; Does AI Promote Bias? Opioid Salesman Tells All

    may promote social, racial, and gender bias ~ Addressing Bias in Artificial Intelligence in Health Care (JAMA)The Lower Drug Costs Now Act signals "a major departure" for how the U.S. plans to regulate drug prices, Stacie B. Dusetzina, PhD, and Jonathan...

    https://mschristian.org/index.php/blog/suing-device-firms-does-ai-promote-bias-opioid-salesman-tells-all
  • Despite Intense Public, Congressional Scrutiny, Pharma Still Hikes Prices For Hundreds Of Drugs In 2020 - Kaiser Health News

    identical to the increases taken last year.” Pharmaceutical companies started 2020 by raising the prices of hundreds of drugs an average of 5.8%, according to a new analysis, a smaller increase than a year prior as the industry faces growing scrutiny...

    https://mschristian.org/index.php/blog/despite-intense-public-congressional-scrutiny-pharma-still-hikes-prices-for-hundreds-of-drugs-in-2020-kaiser-health-news
  • Common treatment for multiple sclerosis may prolong life

    from the University of British Columbia and Vancouver Coastal Health Research Institute have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients. The study, published today in the journal...

    https://mschristian.org/index.php/blog/common-treatment-for-multiple-sclerosis-may-prolong-life
  • What Happened With a Once-Promising Alzheimer's Drug

    Lanabecestat, a once-promising investigational drug for Alzheimer's disease, did not improve cognition, according to two late-stage clinical trials that had been stopped for futility. Despite evidence that amyloid levels were lower, daily lanabecestat...

    https://mschristian.org/index.php/blog/what-happened-with-a-once-promising-alzheimer-s-drug

Results 1 - 20 of 119
 
 

Follow Us on Twitter

Follow Us On Twitter - Image